BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26241947)

  • 1. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
    Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
    Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
    J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
    Saijo M; Ami Y; Suzaki Y; Nagata N; Iwata N; Hasegawa H; Ogata M; Fukushi S; Mizutani T; Sata T; Kurata T; Kurane I; Morikawa S
    J Virol; 2006 Jun; 80(11):5179-88. PubMed ID: 16698998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.
    Eto A; Saito T; Yokote H; Kurane I; Kanatani Y
    Vaccine; 2015 Nov; 33(45):6106-11. PubMed ID: 26319072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
    Kidokoro M; Tashiro M; Shida H
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4152-7. PubMed ID: 15753319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
    J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological responses in humans to the smallpox vaccine LC16m8.
    Johnson BF; Kanatani Y; Fujii T; Saito T; Yokote H; Smith GL
    J Gen Virol; 2011 Oct; 92(Pt 10):2405-2410. PubMed ID: 21715598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
    Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M
    Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
    Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
    JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
    Meseda CA; Mayer AE; Kumar A; Garcia AD; Campbell J; Listrani P; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Clin Vaccine Immunol; 2009 Sep; 16(9):1261-71. PubMed ID: 19605597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
    Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
    Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
    J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC16m8: an attenuated smallpox vaccine.
    Kenner J; Cameron F; Empig C; Jobes DV; Gurwith M
    Vaccine; 2006 Nov; 24(47-48):7009-22. PubMed ID: 17052815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge.
    Vliegen I; Yang G; Hruby D; Jordan R; Neyts J
    Antiviral Res; 2012 Jan; 93(1):160-6. PubMed ID: 22138484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.
    Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
    Clin Vaccine Immunol; 2014 Sep; 21(9):1261-6. PubMed ID: 24990910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.
    Adamo JE; Meseda CA; Weir JP; Merchlinsky MJ
    J Gen Virol; 2009 Nov; 90(Pt 11):2604-2608. PubMed ID: 19587131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.